May 11 (Reuters) - Jubilant Life Sciences Ltd JULS.NS :
- Jubilant and Cyclopharm mutually agree to terminate term sheet for technegas
licensing agreement
- Both parties have agreed to discuss potential commercial opportunities once
CYC obtains USFDA approval for Technegas
- Source text: (http://bit.ly/1VSYcrx)
- Further company coverage
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.005(0.50%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | $1.00 | $215.2K | 211.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10089 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 3762 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |